In addition, findings from preclinical studies highlighted the fact that glatiramer acetate through its immunomodulatory and BDNF effects can decrease the severity of other neurological disorders such as AD and depression [104, 105]. The gene discussed is BDNF; the disease is depressive symptom measurement.